Company Filing History:
Years Active: 2012-2018
As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I'll create an article about inventor Christopher Joseph Pemberton based on the provided data.
Title: Christopher Joseph Pemberton - Innovator in Biomedical Biomarkers
Introduction:
Christopher Joseph Pemberton, a distinguished inventor based in Christchurch, NZ, has made significant contributions to the field of biomedical research. With a remarkable portfolio of 10 patents, Pemberton's innovative work focuses on developing biomarkers for critical medical conditions.
Latest Patents:
His recent patents include groundbreaking inventions such as "Biomarkers for pneumonia and acute decompensated heart failure - Ghrelin signal peptide fragment assays." These assays and kits play a crucial role in diagnosing, prognosing, and monitoring various disorders like pneumonia and heart failure. Additionally, his work on insulin signal peptide binding agents and assays highlights his commitment to predicting and diagnosing acute cardiac disorders and diabetes.
Career Highlights:
Pemberton's career has been marked by collaborations with key players in the industry. He has contributed his expertise to esteemed organizations like Otago Innovation Limited and Upstream Medical Technologies Limited, showcasing his versatility in driving innovation across different platforms.
Collaborations:
Throughout his career, Pemberton has collaborated with respected professionals in the field. Notable coworkers include Arthur Mark Richards and Michael Gary Nicholls, who have played pivotal roles in shaping the trajectory of his groundbreaking research.
Conclusion:
In conclusion, Christopher Joseph Pemberton's pioneering work in developing biomarkers for critical medical conditions underscores his commitment to advancing healthcare through innovation. His patents and collaborative efforts have solidified his reputation as a leading figure in the biomedical research landscape, with a promising future ahead in revolutionizing diagnostic and treatment methods.